The FDA has issued guidelines allowing for faster development of updated coronavirus vaccines, based on previously approved shots that have been tweaked to combat emerging variants of the SARS-CoV ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.

This marks the third year that vaccine manufacturers have updated their COVID-19 vaccine formulations to better ... As it has ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food and Drug Administration (FDA ... or approved monovalent COVID-19 vaccine.

WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID ... FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the ...

FDA places a clinical hold on Novavax's COVID-19-influenza vaccine trials due to a serious adverse event in a Phase 2 participant. Novavax's COVID-19 IND and European approval for its updated ...

The company said it was not yet established that the vaccine had caused the safety event and it was working with the FDA to ... s growth as its COVID-19 shot, Novavax’s only approved product ...

The company said it was not yet established that the vaccine had caused the safety event and it was working with the FDA to resolve ... as its COVID-19 shot, Novavax's only approved product ...

Shares of Moderna (NASDAQ:MRNA) traded ~7% higher in the premarket on Thursday after the company swung back to profits on ...

US FDA approves updated COVID shots ahead of fall and winter The U.S. Food and Drug Administration on Thursday approved updated COVID-19 vaccines made by Pfizer and Moderna targeting a recent ...

The FDA has placed a clinical hold ... Last week, the European Commission approved Novavax’s updated 2024-2025 Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2705), dispersion ...